David LAGIER, MD PhD, Assistance Publique Hôpitaux de Marseille, Marseille, APHM

Efficacité de l'hydroxychloroquine et de l'azithromycine

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

David LAGIER, MD PhD, Assistance Publique Hôpitaux de Marseille, Marseille, APHM

David LAGIER, MD PhD, Assistance Publique Hôpitaux de Marseille, Marseille, APHM

APHM - Assistance Publique - Hôpitaux de Marseille, Hôpital public à Marseille

PDF) X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

David LAGIER, MD PhD, Assistance Publique Hôpitaux de Marseille, Marseille, APHM

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

PRENDRE RENDEZ-VOUS: DR LAGIER DAVID anesthésiste réanimateur à Marseille

David LAGIER, MD PhD, Assistance Publique Hôpitaux de Marseille, Marseille, APHM

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19, Genome Medicine

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

PDF) Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths